儿童青少年注意缺陷多动障碍的治疗:系统综述
该系统综述纳入12个数据库1980年至2023年6月发表的312项研究(540篇出版物),评估药物、心理社会干预、家长支持、营养补充剂等多种治疗对临床诊断ADHD儿童青少年健康与心理社会结局的效果。多种治疗可改善ADHD症状,药物证据最强但伴随不良事件;直接比较替代治疗的研究有限,药物联合青少年导向心理社会干预未系统优于单药治疗。
要点
- 多种治疗可改善ADHD症状,药物证据最强但伴随不良事件。
- 直接比较替代治疗的研究有限,兴奋剂与非兴奋剂间系统性差异少。
- 药物联合青少年导向心理社会干预未系统优于单药治疗。
核心结论
- 越来越多的治疗可改善ADHD症状及其他结局,尤其对学龄期青少年。
- 药物治疗仍是重要选择,但与不良事件相关。
研究设计与样本
- 系统综述,检索12个数据库1980年至2023年6月发表的对照治疗评估,不限干预内容。
- 纳入临床诊断ADHD的儿童青少年研究,报告患者健康与心理社会结局。
- 共纳入312项研究(540篇出版物),由培训过的评审员筛选,机器学习辅助。
- 数据由1名评审员提取并批判性评估,方法学家核查,采用随机效应模型合并。
- 证据强度与适用性评估遵循Evidence-based Practice Center标准。
主要发现
- 证据按药物、心理社会干预、家长支持、营养与补充剂、神经反馈、神经刺激、体育锻炼、补充医学、学校干预和提供者方法分组。
- 多种治疗可改善ADHD症状。
- 药物在改善结局(包括破坏性行为和广泛性测量)方面证据最强,但与不良事件相关。
- 直接比较替代治疗的研究证据有限。
- 间接分析发现兴奋剂与非兴奋剂之间系统性差异很少。
临床怎么用
- 药物治疗仍是ADHD的重要治疗选择,但需关注不良事件。
- 多种非药物干预可改善ADHD症状,尤其适用于学龄期青少年。
- 药物联合青少年导向心理社会干预未显示系统优于单药治疗,选择联合需个体化。
局限性
- 直接比较替代治疗的研究证据有限。
- 间接分析发现兴奋剂与非兴奋剂之间系统性差异很少。
- 药物联合青少年导向心理社会干预评估的组合很少。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Effective treatment of attention-deficit/hyperactivity disorder (ADHD) is essential to improving youth outcomes. OBJECTIVES: This systematic review provides an overview of the available treatment options. DATA SOURCES: We identified controlled treatment evaluations in 12 databases published from 1980 to June 2023; treatments were not restricted by intervention content. STUDY SELECTION: Studies in children and adolescents with clinically diagnosed ADHD, reporting patient health and psychosocial outcomes, were eligible. Publications were screened by trained reviewers, supported by machine learning. DATA EXTRACTION: Data were abstracted and critically appraised by 1 reviewer and checked by a methodologist. Data were pooled using random-effects models. Strength of evidence and applicability assessments followed Evidence-based Practice Center standards. RESULTS: In total, 312 studies reported in 540 publications were included. We grouped evidence for medication, psychosocial interventions, parent support, nutrition and supplements, neurofeedback, neurostimulation, physical exercise, complementary medicine, school interventions, and provider approaches. Several treatments improved ADHD symptoms. Medications had the strongest evidence base for improving outcomes, including disruptive behaviors and broadband measures, but were associated with adverse events. LIMITATIONS: We found limited evidence of studies comparing alternative treatments directly and indirect analyses identified few systematic differences across stimulants and nonstimulants. Identified combination of medication with youth-directed psychosocial interventions did not systematically produce better results than monotherapy, though few combinations have been evaluated. CONCLUSIONS: A growing number of treatments are available that improve ADHD symptoms and other outcomes, in particular for school-aged youth. Medication therapies remain important treatment options but are associated with adverse events.
引用
- Peterson BS, Trampush J, Maglione M, et al. Treatments for ADHD in Children and Adolescents: A Systematic Review. Pediatrics. 2024. PMID: 38523592. doi:10.1542/peds.2024-065787
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。